Effectiveness of Hemopatch® versus Surgicel® Original to control mild and moderate liver bleeding
Authors:
Open Access
- 14 August 2022
- journal article
- research article
- Published by Springer Nature in BMC Surgery
- Vol. 22 (1) , 1-7
Abstract
Background: Adjunct hemostats can be of use in certain surgical settings. We compared the effectiveness of two hemostats, Hemopatch® and Surgicel® Original in controlling bleeding from liver lesions in an experimental model. Methods: Control of grades 1 (mild) and 2 (moderate) bleeding (according to the Validated Intraoperative Bleeding [VIBe] SCALE) was assessed for 10 min after Hemopatch® (n = 198) or Surgicel® Original (n = 199) application on 397 liver surface lesions. The primary endpoint was hemostatic success (reaching VIBe SCALE grade 0 at 10 min). The secondary endpoint was time to hemostasis (time to reach and maintain grade 0). A generalized linear mixed model and an accelerated failure time model were used to assess the primary and secondary endpoints, respectively. Results: The overall hemostatic success rate of Hemopatch® was statistically significantly superior to that of Surgicel® Original (83.8% versus 73.4%; p = 0.0036; odds ratio [OR] 2.38, 95% confidence interval [CI] 1.33–4.27) and time to hemostasis was reduced by 15.9% (p = 0.0032; 95% CI 0.749–0.944). Grade 2 bleeds treated with Hemopatch® had statistically significantly higher hemostatic success (71.7% versus 48.5%; p = 0.0007; OR 2.97, 95% CI 1.58–5.58) and shorter time to hemostasis (49.6% reduction, p = 3.6 × 10–8); differences for grade 1 bleeds (hemostatic success rate or time to hemostasis) were not statistically significant. Conclusions: Hemopatch® provided better control of VIBe SCALE bleeding compared to Surgicel® Original for Grade 2 bleeds in this porcine model, highlighting the importance of choosing a suitable hemostat to optimize control of bleeding during surgery.Keywords
This publication has 29 references indexed in Scilit:
- Treatment of Severe Aortic Bleeding Using Hemopatch in Swine on Dual Antiplatelet TherapyJournal of Investigative Surgery, 2016
- Safety and effectiveness of a synthetic hemostatic patch for intraoperative soft tissue bleedingMedical Devices: Evidence and Research, 2015
- European Initial Hands-On Experience with HEMOPATCH, a Novel Sealing Hemostatic Patch: Application in General, Gastrointestinal, Biliopancreatic, Cardiac, and Urologic Surgery.2014
- A Prospective, Randomized, Controlled Trial of the Efficacy and Safety of Fibrin Pad as an Adjunct to Control Soft Tissue Bleeding During Abdominal, Retroperitoneal, Pelvic, and Thoracic SurgeryJournal of the American College of Surgeons, 2013
- Comparison of Two Gelatin and Thrombin Combination Hemostats in a Porcine Liver Abrasion ModelJournal of Investigative Surgery, 2013
- Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patientsBMC Health Services Research, 2011
- Topical Hemostatic Agents in Surgery: A Surgeon's PerspectiveAORN Journal, 2008
- Acute in-vivo evaluation of bleeding with GelfoamTM plus saline and Gelfoam plus human thrombin using a liver square lesion model in swineJournal of Thrombosis and Thrombolysis, 2008
- Pathophysiology of Bleeding in SurgeryTransplantation Proceedings, 2006
- Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgeryThe American Journal of Surgery, 1979